Transfusion-dependent Iron Overload
📧 Sign up to get email alerts when something new happens for Transfusion-dependent Iron Overload.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2007-12-21FDA Approved: EXJADE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for EXJADE (deferasirox) by Novartis Pharmaceuticals Corporation, updating the product labeling.